News tagged with 'Remicade'

The FDA is requiring TNF blockers to carry stronger warnings highlighting the increased risk of cancer in children and adolescents who receive these drugs to treat juvenile rheumatoid arthritis and other inflammatory diseases.

The manufacturers of arthritis drugs have been ordered to strengthen existing warnings on the drugs’ prescribing information and Medication Guides, on the risk of developing a possibly fatal fungal infection.

Over the past several years, two rheumatoid arthritis drugs have been approved, making successful treatment of painful arthritis symptoms a reality for thousands of patients worldwide. These two drugs, Enbrel and Remicade, act to inhibit tumor necrosis factor (TNF), a cause of arthritic pain. In August 2001 the Fo